Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2024-10-30
Target enrollment:
Participant gender:
Summary
Assess serum and tissue retinol binding protein 4 in patients with severe alopecia areata in correlation with healthy individuals .
Estimate genetic profile of retinol binding protein4 in severe alopecia areata patients
Assess possible role of retinol binding protein 4 genetic mutation in response to barcitinib treatment in patients with severe alopecia areata .